Balyasny Asset Management »

Xilio Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $258k 273k 0.95
2024-03-31 $366k 339k 1.08

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
Morgan Stanley
Vanguard Group
Geode Capital Management
Balyasny Asset Management
Renaissance Technologies
BlackRock
Bridgeway Capital Management
BlackRock
State Street Corporation
SevenBridge Financial
Northern Trust
Raymond James & Associates

View all funds holding Xilio Therapeutics